First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q3 2025 (September 30)19holders +1
2new positions
1sold out
$28.52avg. 13F price*
At the end of Q3 2025, 19 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were LPL Financial LLC ($3.0M), Goldman Sachs Group Inc. ($904K) and Envestnet Asset Management Inc. ($517K).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $372K |
| Exits | 1 | $57K |
All 13F filers, Q2 2025 → Q3 2025: 17,141 shares bought and 11,480 shares sold, net +5,661 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| LPL Financial LLC | 0.00% | Reduce -4.6% | 103,958 | $3.0M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -1.5% | 31,702 | $904K |
| Envestnet Asset Management Inc. | 0.00% | Add +2.1% | 18,132 | $517K |
| Ameritas Investment Partners, Inc. | 0.01% | Add +9.7% | 17,232 | $491K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Reduce -10.1% | 15,273 | $436K |
| WMG Financial Advisors, LLC | 0.10% | Reduce -0.9% | 10,726 | $306K |
| Debussy Capital Management LP | 0.04% | Add +4.1% | 9,790 | $279K |
| Bank of Montreal | 0.00% | Add +12.2% | 9,224 | $263K |
| Stratos Wealth Partners, LTD. | 0.00% | New | 8,062 | $230K |
| Morgan Stanley | 0.00% | No change | 5,916 | $169K |
| Steph & Co. | 0.04% | New | 4,990 | $142K |
| UBS Group AG | 0.00% | Add +20.4% | 4,810 | $137K |
| Osaic Holdings, Inc. | 0.00% | Reduce -8.0% | 3,032 | $84K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -60.5% | 1,076 | $31K |
| Lanark Financial, Inc. | 0.00% | No change | 996 | $28K |
| Harbour Investments, Inc. | 0.00% | No change | 836 | $24K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $17K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $13K |
| Wells Fargo & Company | 0.00% | No change | 1 | $29 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.